A propensity score-matched NSQIP analysis comparing open, laparoscopic, and robotic approaches for total abdominal colectomy with end ileostomy in inflammatory bowel disease Authors: I. S. Alam, H. H. Aydinli, Z. Gajic, C. Atallah, B. Safar, J. Simon, M. J. Grieco, A. da Luz Moreira Published: 2026 ABSTRACT BackgroundMinimally invasive surgical techniques have improved outcomes in colorectal surgery, but comparative data on their use in total abdominal colectomy with end ileostomy for inflammatory bowel disease remain limited. This study aimed to compare postoperative outcomes among patients undergoing robotic, laparoscopic, or open total abdominal colectomy for inflammatory bowel disease.MethodsWe performed a retrospective cohort analysis using propensity score matching to control for baseline differences across patients. Data were obtained from the 2022 American College of Surgeons National Surgical Quality Improvement Program, a national surgical outcomes registry. Adult patients who underwent total abdominal colectomy with end ileostomy for ulcerative colitis or Crohn’s disease were included. Patients were treated with robotic-assisted, laparoscopic, or open total abdominal colectomy with end ileostomy. The primary outcome was any postoperative complication within 30 days of surgery. Secondary outcomes included operative time, conversion to open surgery, length of hospital stay, 30-day readmission, and other specific postoperative complications such as surgical site infection and renal insufficiency.ResultsA total of 581 matched patients were analyzed, including 83 robotic, 415 laparoscopic, and 83 open cases. There were no significant differences in overall 30-day morbidity across groups. Robotic surgery had significantly longer operative time than laparoscopic but not open surgery. Organ space infections and renal complications were more common in the robotic group compared with laparoscopic. Although robotic surgery was associated with shorter hospital stay, it also had the highest 30-day readmission rate.ConclusionsRobotic total abdominal colectomy demonstrated similar overall morbidity and conversion rates compared with other approaches but was associated with longer operative time, increased complications, and higher readmissions. Further refinement of perioperative protocols and patient selection may improve outcomes. Introduction Minimally invasive surgical techniques have significantly advanced colorectal surgery, offering substantial benefits over traditional open procedures. The adoption of laparoscopic approaches has been associated with reduced postoperative pain, shorter hospital stays, and lower rates of surgical site infections compared with open surgery. These advantages have been well-documented in segmental colectomies, particularly for right and left colectomies [1, 2]. However, data on their applicability to total abdominal colectomy (TAC) remain limited. In the context of inflammatory bowel disease (IBD), substantial evidence already supports the benefits of minimally invasive approaches—including for total colectomy [3, 4]. However, data specifically evaluating robotic-assisted surgery in this patient population remain relatively limited, highlighting the need for further investigation. TAC is often performed for medically refractory IBD, including Crohn’s disease and ulcerative colitis (UC), and may also be indicated for hereditary cancer syndromes or severe colonic dysmotility disorders [3, 4]. Traditionally, TAC has been conducted via an open approach (OTAC) owing to the complexity of the procedure and the need for extensive intra-abdominal dissection. However, with advancements in minimally invasive surgery, laparoscopic TAC (LTAC) and robotic-assisted TAC (RTAC) have emerged as viable alternatives [5, 6]. Compared with segmental colectomy, robotic TAC poses additional technical challenges, including the need for multiquadrant access, complex port placement, and potentially longer operative times, all of which may impact adoption, efficiency, and outcomes. While minimally invasive surgery is increasingly favored, few studies have directly evaluated LTAC versus RTAC, and questions remain regarding their comparative efficacy and safety [3, 7, 8]. Prior studies evaluating laparoscopic versus open approaches for TAC have demonstrated reduced postoperative complications, shorter length of stay (LOS), and faster recovery with laparoscopy [9]. These findings support the benefits of minimally invasive techniques in TAC, although further research is needed to delineate the role of robotic surgery and directly compare its outcomes with laparoscopic and open approaches in IBD. This study aims to leverage American College of Surgeons (ACS)-National Surgical Quality Improvement Program (NSQIP) data to compare postoperative outcomes among patients undergoing TAC via open, laparoscopic, and robotic-assisted approaches, with particular attention to morbidity, LOS, conversion rates, and readmissions. By providing a comprehensive assessment of these three surgical techniques, we aim to inform clinical decision-making and choice of surgical approach for patients requiring TAC in IBD. Materials and methods Data source This was a retrospective cohort study utilizing the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) Participant Use Data File for the year 2022. We limited the study to this year because 2022 was the first and only year in NSQIP where robotic-assisted and laparoscopic total abdominal colectomy could be reliably differentiated. Patient selection Patients with a diagnosis of UC or Crohn’s disease were identified using International Classification of Diseases, 10th Revision (ICD-10) codes K50 and K51. Exclusion criteria included patients who underwent pouch-related procedures (Current Procedural Terminology [CPT] codes 44,151, 44,156, 44,157, 44,158) and those with implausible data entries, defined as a hospital length of stay or body mass index (BMI) less than zero. After applying inclusion and exclusion criteria, 930 patients were included in the final cohort. Variable definitions Comorbidities were defined by positive entries in any of the following NSQIP variables: history of diabetes, current smoker within the past year, history of chronic obstructive pulmonary disease, presence of ascites within 30 days before surgery, history of congestive heart failure within 30 days before surgery, hypertension requiring medication, acute renal failure or currently on dialysis, disseminated cancer, chronic steroid use for a medical condition, bleeding disorder or use of chronic anticoagulation increasing bleeding risk, transfusion of more than four units of red blood cells in the 72 h prior to surgery, or preoperative systemic sepsis (including systemic inflammatory response syndrome [SIRS], sepsis, or septic shock within 48 h before surgery). Composite postoperative complications were defined by the presence of any of the following variables: superficial surgical site infection, deep incisional surgical site infection, organ/space surgical site infection, wound disruption or dehiscence, postoperative pneumonia, unplanned intubation, pulmonary embolism, failure to wean from ventilator > 48 h, progressive renal insufficiency, acute renal failure requiring dialysis, urinary tract infection, stroke or cerebrovascular accident with neurological deficit, cardiac arrest requiring cardiopulmonary resuscitation (CPR), myocardial infarction, postoperative bleeding requiring transfusion or intervention, deep vein thrombosis requiring therapy, systemic sepsis, or septic shock. Matching procedure Cohort matching was performed using the MatchIt package in R (v4.4.1), employing nearest-neighbor matching without replacement. Matching variables included age, BMI, and all comorbidities as listed above under variable definitions as well as the additional NSQIP variables: race, sex, American Society of Anesthesiologists (ASA) physical status classification, and case type (elective, urgent, or emergent). Robotic cases were first matched to minimally invasive (laparoscopic) cases at ratios of 1:5 (entire cohort), 1:4 (UC), and 1:3 (Crohn’s disease). Robotic cases were then matched to open cases using 1:1 (entire cohort and UC) and 1:3 (Crohn’s disease) ratios. Statistical analysis Comparisons of continuous variables were conducted using the Wilcoxon rank-sum test with continuity correction. Categorical variables were analyzed using Pearson’s chi-squared test with Yates’ continuity correction. All analyses were performed using R (v4.4.1), with the following packages: MatchIt (v4.7.1), esc (v0.5.1), plyr (v1.8.9), dplyr (v1.1.4), ggplot2 (v3.5.1), readxl (v1.4.5), and data.table (v1.17.0). To further address residual confounding not eliminated by propensity score matching, multivariable regression analyses were performed. Results A total of 930 patients (83 RTAC, 655 LTAC, and 192 OTAC) met the inclusion criteria. Propensity score matching resulted in 83 patients in the RTAC group, 415 patients in the LTAC group, and 83 patients in the OTAC group. Figure 1 depicts the selection of the final cohort included in the study and summarizes the primary and secondary outcomes that were analyzed. In total, 581 matched patients were included in the study, with a median age of 40 years (IQR: 25). Female patients comprised 44.8% of the cohort, 85.7% were white, and 91.4% underwent elective surgery. UC was the primary diagnosis in the majority of robotic (78.3%) and laparoscopic (78.8%) cases, whereas Crohn’s disease predominated in the open approach group (66.3%). The groups were well matched by case urgency, with elective procedures comprising the majority—91.6% in the robotic and laparoscopic groups and 90.4% in the open group—while the remainder were classified as urgent. The preoperative demographic and clinical characteristics were overall well-matched between groups (Table 1).Fig. 1Flow diagram depicting cohort selection process and summary of primary and secondary outcomes analyzedTable 1Demographic and preoperative patient characteristics in patients undergoing robotic, laparoscopic, and open total abdominal colectomyPreoperative patient characteristicsRobotic approach, N = 83Laparoscopic approach, N = 415Open approach, N = 83Robotic versus laparoscopic, p-valueRobotic versus open, p-valueASA Class 242 (50.6%)218 (52.5%)34 (41.0%)0.80.3ASA Class 340 (48.2%)193 (46.5%)49 (59.0%)0.90.2ASA Class 41 (1.2%)4 (1.0%)0 (0%)11Age (years)45 (22.5)39 (26.5)44 (21)0.50.6Female37 (44.6%)185 (44.6%)38 (45.8%)11Male46 (55.4%)230 (55.4%)45 (54.2%)11BMI25.9 (8.7)25.6 (8.8)26.2 (8.5)0.30.7Black or African American4 (4.8%)19 (4.6%)7 (8.4%)10.5White72 (86.8%)358 (86.3%)68 (81.9%)10.5Asian/Hawaiian2 (2.4%)14 (3.4%)1 (1.2%)0.91Other5 (6.0%)24 (5.8%)7 (8.4%)10.8Crohn’s disease18 (21.7%)88 (21.2%)55 (66.3%)1< 0.001Ulcerative colitis65 (78.3%)327 (78.8%)28 (33.7%)1< 0.001Bleeding disorder1 (1.2%)2 (0.5%)1 (1.2%)11Nondiabetic75 (90.4%)382 (92.1%)77 (92.8%)0.80.8Noninsulin dependent diabetes4 (4.8%)18 (4.3%)3 (3.6%)11Insulin dependent diabetes4 (4.8%)15 (3.6%)3 (3.6%)0.81Hypertension15 (18.1%)72 (17.4%)16 (19.3%)11Kidney disease1 (1.2%)4 (1.0%)1 (1.2%)11Smoker over past year7 (8.4%)24 (5.8%)11 (13.3%)0.50.5Use of steroids or immunosuppressive therapy60 (72.3%)311 (74.9%)65 (78.3%)0.70.5Transfusion requirement2 (2.4%)8 (1.9%)3 (3.6%)11Systemic inflammatory response5 (6.0%)17 (4.1%)3 (3.6%)0.60.7Number of comorbidities1 (0.5)1 (0)1 (1)0.70.4Elective case76 (91.6%)380 (91.6%)75 (90.4%)11Urgent case7 (8.4%)35 (8.4%)8 (9.6%)11Values are reported as N (%) or median (IQR) Flow diagram depicting cohort selection process and summary of primary and secondary outcomes analyzed Table 1Demographic and preoperative patient characteristics in patients undergoing robotic, laparoscopic, and open total abdominal colectomyPreoperative patient characteristicsRobotic approach, N = 83Laparoscopic approach, N = 415Open approach, N = 83Robotic versus laparoscopic, p-valueRobotic versus open, p-valueASA Class 242 (50.6%)218 (52.5%)34 (41.0%)0.80.3ASA Class 340 (48.2%)193 (46.5%)49 (59.0%)0.90.2ASA Class 41 (1.2%)4 (1.0%)0 (0%)11Age (years)45 (22.5)39 (26.5)44 (21)0.50.6Female37 (44.6%)185 (44.6%)38 (45.8%)11Male46 (55.4%)230 (55.4%)45 (54.2%)11BMI25.9 (8.7)25.6 (8.8)26.2 (8.5)0.30.7Black or African American4 (4.8%)19 (4.6%)7 (8.4%)10.5White72 (86.8%)358 (86.3%)68 (81.9%)10.5Asian/Hawaiian2 (2.4%)14 (3.4%)1 (1.2%)0.91Other5 (6.0%)24 (5.8%)7 (8.4%)10.8Crohn’s disease18 (21.7%)88 (21.2%)55 (66.3%)1< 0.001Ulcerative colitis65 (78.3%)327 (78.8%)28 (33.7%)1< 0.001Bleeding disorder1 (1.2%)2 (0.5%)1 (1.2%)11Nondiabetic75 (90.4%)382 (92.1%)77 (92.8%)0.80.8Noninsulin dependent diabetes4 (4.8%)18 (4.3%)3 (3.6%)11Insulin dependent diabetes4 (4.8%)15 (3.6%)3 (3.6%)0.81Hypertension15 (18.1%)72 (17.4%)16 (19.3%)11Kidney disease1 (1.2%)4 (1.0%)1 (1.2%)11Smoker over past year7 (8.4%)24 (5.8%)11 (13.3%)0.50.5Use of steroids or immunosuppressive therapy60 (72.3%)311 (74.9%)65 (78.3%)0.70.5Transfusion requirement2 (2.4%)8 (1.9%)3 (3.6%)11Systemic inflammatory response5 (6.0%)17 (4.1%)3 (3.6%)0.60.7Number of comorbidities1 (0.5)1 (0)1 (1)0.70.4Elective case76 (91.6%)380 (91.6%)75 (90.4%)11Urgent case7 (8.4%)35 (8.4%)8 (9.6%)11Values are reported as N (%) or median (IQR) Demographic and preoperative patient characteristics in patients undergoing robotic, laparoscopic, and open total abdominal colectomy Values are reported as N (%) or median (IQR) Univariate analysis (Table 2) showed no significant difference in 30-day postoperative morbidity between the RTAC (30.1%) and LTAC (22.9%, p = 0.21) or OTAC (36.1%, p = 0.51) groups (Fig. 2). Mean operative time was significantly longer for RTAC (300.8 ± 119.8 min) compared with LTAC (227.8 ± 82.2 min) with a mean difference of 72.97 min (p < 0.001). No significant difference was found between RTAC and OTAC (268.3 ± 145.8 min), with a mean difference of 32.43 min (p = 0.12). The rate of unplanned conversion to open surgery was comparable between RTAC (9.6%) and LTAC (7.2%, p = 0.60). Conversion rates to open surgery did not differ between urgent and elective cases (6.0% versus 6.6%, p = 1.0). Table 2Postoperative outcomes in patients undergoing robotic, laparoscopic, and open total abdominal colectomyPostoperative outcomeRobotic approach, N = 83Laparoscopic approach, N = 415Open approach, N = 83Robotic versus laparoscopic, p-ValueRobotic versus open, p-ValuePostoperative 30-day morbidity25 (30.1%)95 (22.9%)30 (36.1%)0.20.5Operative time300.8 (119.8)227.8 (82.2)268.3 (145.8)< 0.0010.1Unplanned conversion8 (9.6%)30 (7.2%)0 (0%)0.60.01Sepsis5 (6.0%)6 (1.5%)5 (6.0%)0.31Septic shock1 (1.2%)4 (1.0%)3 (3.6%)10.6Superficial surgical site infection0 (0%)12 (2.9%)4 (4.8%)0.240.1Deep incisional surgical site infection1 (1.2%)0 (0%)1 (1.2%)0.41Organ space surgical site infection12 (14.5%)18 (4.3%)10 (12.1%)0.0010.8Wound dehiscence2 (2.4%)3 (0.7%)1 (1.2%)0.41Pneumonia1 (1.2%)3 (0.7%)3 (3.6%)10.6Urinary tract infection1 (1.2%)2 (0.5%)1 (1.2%)11Renal insufficiency9 (10.8%)13 (3.1%)7 (8.4%)0.0050.8DVT requiring therapy6 (7.2%)13 (3.1%)2 (2.4%)0.10.3Pulmonary embolism1 (1.2%)1 (0.2%)1 (1.2%)0.81Blood transfusion requirement9 (10.8%)51 (12.3%)14 (16.9%)0.90.4Failure to wean off ventilator > 48 h0 (0%)1 (0.2%)3 (3.6%)10.2Unplanned intubation0 (0%)2 (0.5%)2 (2.4%)10.5Return to operating room6 (7.2%)18 (4.3%)4 (4.8%)0.40.7Total hospital length of stay5 (7)6 (8)8 (7)0.050.00230-day readmission17 (20.5%)41 (9.9%)11 (13.3%)0.010.3Values are reported as N (%) or median (IQR). Only operative time is reported as mean (SD)Fig. 2Proportion of patients experiencing at least one postoperative complication after robotic (RTAC), laparoscopic (LTAC), and open (OTAC) total abdominal colectomy. Error bars represent 95% confidence intervals Table 2Postoperative outcomes in patients undergoing robotic, laparoscopic, and open total abdominal colectomyPostoperative outcomeRobotic approach, N = 83Laparoscopic approach, N = 415Open approach, N = 83Robotic versus laparoscopic, p-ValueRobotic versus open, p-ValuePostoperative 30-day morbidity25 (30.1%)95 (22.9%)30 (36.1%)0.20.5Operative time300.8 (119.8)227.8 (82.2)268.3 (145.8)< 0.0010.1Unplanned conversion8 (9.6%)30 (7.2%)0 (0%)0.60.01Sepsis5 (6.0%)6 (1.5%)5 (6.0%)0.31Septic shock1 (1.2%)4 (1.0%)3 (3.6%)10.6Superficial surgical site infection0 (0%)12 (2.9%)4 (4.8%)0.240.1Deep incisional surgical site infection1 (1.2%)0 (0%)1 (1.2%)0.41Organ space surgical site infection12 (14.5%)18 (4.3%)10 (12.1%)0.0010.8Wound dehiscence2 (2.4%)3 (0.7%)1 (1.2%)0.41Pneumonia1 (1.2%)3 (0.7%)3 (3.6%)10.6Urinary tract infection1 (1.2%)2 (0.5%)1 (1.2%)11Renal insufficiency9 (10.8%)13 (3.1%)7 (8.4%)0.0050.8DVT requiring therapy6 (7.2%)13 (3.1%)2 (2.4%)0.10.3Pulmonary embolism1 (1.2%)1 (0.2%)1 (1.2%)0.81Blood transfusion requirement9 (10.8%)51 (12.3%)14 (16.9%)0.90.4Failure to wean off ventilator > 48 h0 (0%)1 (0.2%)3 (3.6%)10.2Unplanned intubation0 (0%)2 (0.5%)2 (2.4%)10.5Return to operating room6 (7.2%)18 (4.3%)4 (4.8%)0.40.7Total hospital length of stay5 (7)6 (8)8 (7)0.050.00230-day readmission17 (20.5%)41 (9.9%)11 (13.3%)0.010.3Values are reported as N (%) or median (IQR). Only operative time is reported as mean (SD) Postoperative outcomes in patients undergoing robotic, laparoscopic, and open total abdominal colectomy Values are reported as N (%) or median (IQR). Only operative time is reported as mean (SD) Proportion of patients experiencing at least one postoperative complication after robotic (RTAC), laparoscopic (LTAC), and open (OTAC) total abdominal colectomy. Error bars represent 95% confidence intervals The most common complications included organ space surgical site infections (14.5% RTAC versus 4.3% LTAC, p = 0.001; and 12.1% OTAC, p = 0.82), bleeding requiring transfusion (10.8% RTAC versus 12.3% LTAC, p = 0.85; and 16.9% OTAC, p = 0.37), and renal insufficiency (10.8% RTAC versus 3.1% LTAC, p = 0.005; and 8.4% OTAC, p = 0.79). On multivariable regression, steroid use (odds ratio [OR] 2.06, 95% confidence interval [CI] 1.22–3.49, p = 0.007), perioperative transfusion (OR 1.92, 95% CI 1.09–3.40, p = 0.024), and urgent case status (OR 2.13, 95% CI 1.09–4.14, p = 0.028) were independent predictors of morbidity, whereas surgical approach (RTAC versus LTAC or OTAC) was not significantly associated with 30-day outcomes (p > 0.4 for both comparisons). Overall, operations complicated by SSI were longer than those without, with statistically significant differences observed in the entire cohort (263.5 versus 220 min, p = 0.015) and among patients with Crohn’s disease (406.5 versus 250 min, p = 0.004). A similar trend was seen in the UC group (246.6 versus 210 min), though this did not reach statistical significance (p = 0.45). Median length of stay was shorter for RTAC (5 days, IQR: 7) compared with LTAC (6 days, IQR: 8, p = 0.04) and OTAC (8 days, IQR: 7, p = 0.002). However, the 30-day readmission rate was higher in the RTAC group (20.5%) compared with LTAC (9.9%, p = 0.01) and OTAC (13.3%, p = 0.30). Discussion This study provides a comprehensive comparison of robotic-assisted total abdominal colectomy (RTAC), laparoscopic TAC (LTAC), and open TAC (OTAC), offering valuable insight into postoperative outcomes among these surgical approaches. While no significant difference was found in overall 30-day morbidity between the three groups, our findings suggest important differences in secondary outcomes, particularly operative time, organ space infection rates, renal complications, length of stay, and readmission rates. Importantly, multivariable regression confirmed that overall morbidity was not independently associated with surgical approach; instead, steroid use, perioperative transfusion, and urgent case status emerged as significant predictors of adverse outcomes. The longer operative time observed with RTAC compared with LTAC aligns with previous studies indicating that robotic procedures are often associated with increased operative duration, likely owing to factors such as the learning curve, docking time, and additional setup requirements [7, 10–12]. Especially in a total abdominal colectomy, there is added time in robotic surgery given the need to re-dock the robot during the case. The lack of a significant difference in operative time between RTAC and OTAC should be interpreted with caution because the OTAC group included a significantly higher proportion of patients with Crohn’s disease compared with the RTAC and LTAC groups. Crohn’s colitis cases are inherently more technically challenging owing to transmural inflammation, dense adhesions, and a thickened mesentery, all of which can increase dissection difficulty and operative time. This could have contributed to the unexpectedly prolonged median operative time in OTAC, despite open surgery generally being selected for expediency in sicker patients or those requiring rapid intervention. Therefore, the similarity in operative times between OTAC and RTAC may reflect underlying case complexity rather than true procedural equivalence. This highlights a limitation of our analysis: the three operative cohorts were not perfectly homogeneous in their case mix, which may have influenced comparisons of technical efficiency and operative duration across groups. RTAC was associated with a higher rate of organ space surgical site infections (SSI) compared with LTAC and similar rate when compared with OTAC, echoing concerns raised in earlier research about potential infection risks in complex robotic procedures [8, 13, 14]. The mechanism may involve longer operative time, increased use of energy devices, or challenges in managing intraoperative contamination during extensive dissection in patients with IBD, potentially offsetting the expected advantage of minimally invasive approaches. For this cohort specifically, an important consideration for increased organ space SSI could be due to more rectal stump leaks. Nonetheless, there is a lack of information regarding how the rectal stump was managed in our cohort of patients. In our institution, the rectal stump is kept long and routinely tacked under the fascia at the specimen extraction site or matured as a mucous fistula for those patients with severe colonic inflammation to prevent deep organ space surgical site infections. Unfortunately, NSQIP does not capture details, such as type of stapler used, rectal stump management, or the occurrence of missed enterotomies, limiting our ability to determine the precise mechanism underlying the increased risk of organ space SSI in RTAC. Likewise, hospital- and surgeon-level identifiers are not available, so we cannot assess whether outcomes were disproportionately influenced by a few high-volume centers or by variability in robotic experience. While the higher rate of organ space SSI in RTAC did not translate into a longer median LOS, this discrepancy may reflect differences in institutional Enhanced Recovery After Surgery (ERAS) protocols, which are not captured in NSQIP and may have facilitated earlier discharges despite complications. The higher readmission rate in patients undergoing RTAC supports the idea that several of these infections may have manifested after discharge. Renal insufficiency was also observed more frequently in the RTAC group compared with LTAC. This finding, which has not been widely reported in prior studies, warrants further investigation. Hypotheses may include prolonged pneumoperitoneum affecting renal perfusion or fluid shifts during longer robotic procedures [15, 16]. Enhanced intraoperative monitoring and fluid management protocols may mitigate this risk. Although the NSQIP database does not provide detailed readmission data, it is reasonable to postulate that several patients undergoing RTAC were readmitted for high ileostomy output, especially those with shorter length of hospital stay and early discharge, which may have contributed to the development of acute kidney injury—suggesting a possible association between the two. Conversion rates were comparable between robotic and laparoscopic approaches and were analyzed on an intention-to-treat basis, including patients who required conversion to open surgery. Our findings show that conversion was not influenced by urgency of the case and may instead reflect heterogeneity in surgeon experience, case selection, or institutional volume with robotic total abdominal colectomy. A notable benefit of RTAC was the significantly shorter median LOS compared with both LTAC and OTAC. This aligns with existing evidence supporting faster recovery following minimally invasive colectomies [1, 2]. For instance, a study by Moghadamyeghaneh et al. found that minimally invasive approaches to TAC are associated with lower mortality and morbidity compared with open surgery [3]. Additionally, Mark-Christensen et al. reported that LTAC for IBD is associated with lower short-term mortality and morbidity compared with OTAC [4]. Enhanced visualization, reduced tissue trauma, and improved ergonomics during robotic surgery may contribute to earlier ambulation and gastrointestinal recovery. However, this advantage is tempered by the significantly higher 30-day readmission rate observed in the RTAC group. Similar findings have been reported in several studies, raising the possibility that earlier discharge may predispose certain patients to postdischarge complications or unrecognized issues requiring readmission [3, 14, 17]. These results suggest a nuanced risk–benefit profile for RTAC. While it offers enhanced recovery and shorter hospitalization, it may be associated with increased postoperative complications, including infections and renal insufficiency, and higher readmission rates. LTAC remains a strong alternative, offering a favorable balance of operative efficiency, lower complication rates, and acceptable LOS. Our findings reinforce previous reports demonstrating the feasibility and safety of minimally invasive TAC in IBD and other indications [4, 7] while also highlighting areas where robotic approaches may require further refinement. As robotic technology continues to evolve, improvements in operative efficiency, team experience, and perioperative care protocols will be critical to fully realize its benefits [18–20]. This study has several limitations inherent to its retrospective design and use of a national database. A key limitation of this analysis is the inability of the ACS-NSQIP database to stratify patients with IBD by disease severity. In addition, it cannot distinguish between corticosteroids and other preoperative immunomodulators, such as biologic agents, which are commonly used in the management of inflammatory bowel disease. While corticosteroids have been consistently linked to an increased risk of postoperative infectious complications, multiple studies suggest that biologic therapies—particularly tumor necrosis factor (TNF) inhibitor agents—do not significantly elevate this risk [21–24]. Another important limitation is that NSQIP does not provide hospital- or surgeon-level identifiers, which prevents adjustment for clustering by center or provider. As a result, we were unable to account for institutional ERAS protocols, perioperative care pathways, or variability in surgeon experience with robotic surgery, all of which may influence outcomes. Additionally, superficial SSI rates were lower than expected, likely owing to underreporting. These infections rely on clinical diagnosis and documentation, which may be missed, unlike organ space infections that are typically confirmed by imaging and more reliably recorded. Overall, while NSQIP offers a robust, standardized dataset for surgical outcomes research, its lack of granularity and reliance on accurate clinical documentation can limit the depth of analysis and introduce potential reporting bias. Furthermore, NSQIP does not capture markers of disease severity in inflammatory bowel disease, limiting the ability to adjust for baseline clinical acuity and potentially confounding outcome comparisons. Future research should focus on long-term outcomes, quality-of-life assessments, and cost-effectiveness comparisons among the three approaches. Additionally, further studies are needed to identify which patient populations are most likely to benefit from RTAC and to establish standardized protocols that reduce the risk of complications and readmissions.